Hepatic calcified granuloma is a calcified residual lesion remaining in the liver parenchyma as a healed sequela of past granulomatous infection (tuberculosis, histoplasmosis, brucellosis, schistosomiasis) or granulomatous diseases such as sarcoidosis. Most commonly detected incidentally and does not indicate active disease. Appears as a punctate or small dense calcification focus on CT and shows no enhancement. It is one of the most commonly encountered benign liver calcifications worldwide; prevalence can reach 5-10% in TB or histoplasmosis endemic regions. Clinically completely asymptomatic and requires no treatment — its main significance is differentiation from other calcified liver lesions (metastasis, fibrolamellar HCC, mucinous neoplasm).
Age Range
20-90
Peak Age
-
Gender
Equal
Prevalence
Common
Granuloma formation is a macrophage-mediated immune response attempting to isolate infectious agents or foreign material. In tuberculosis mycobacteria, in histoplasmosis fungal spores, or in sarcoidosis an unknown antigen is the triggering factor. Active granuloma is an organized inflammatory structure consisting of central caseous necrosis surrounded by epithelioid histiocytes, giant cells (Langhans type), and lymphocytes. During healing, the necrotic center undergoes fibrosis and calcium phosphate (hydroxyapatite) crystals precipitate — this dystrophic calcification process takes months to years. Complete calcification indicates that active inflammation has ended. The dense calcification appearance on CT is due to hydroxyapatite crystals containing high atomic number calcium and phosphorus that strongly absorb X-rays. Calcified granuloma is avascular — therefore shows no enhancement whatsoever, which distinguishes it from active granulomatous disease and malignant lesions.
Small, dense, sharp-bordered calcification focus in liver parenchyma — complete absence of surrounding soft tissue component and enhancement. This combination is the pathognomonic CT finding of healed granuloma and requires no further diagnostic workup.
Punctate or small (usually <10 mm), dense (>100 HU, often >200 HU) calcification focus in liver parenchyma on non-contrast CT. Smooth-bordered, round or oval shaped. No density change or mass effect in surrounding parenchyma. May be multiple with random distribution. Concurrent splenic calcifications strengthen granulomatous etiology.
Report Sentence
A _ mm dense calcification focus is identified in the liver parenchyma without mass effect or density change in the surrounding parenchyma; consistent with calcified granuloma related to prior granulomatous infection.
On contrast-enhanced CT (arterial, portal venous, and delayed phases) the calcified granuloma shows no enhancement whatsoever. The calcification remains as an unchanged dense hyperdense focus in all phases. This finding proves the lesion is completely avascular and metabolically inert — differentiates from active infection, inflammation, or neoplasm.
Report Sentence
The calcified lesion shows no enhancement on contrast-enhanced phases; no findings suggesting active disease.
Small, hyperechoic focus with posterior acoustic shadowing on B-mode ultrasonography. Shadowing may be mild or prominent depending on calcification size. Very small calcifications (<3 mm) may not be detected on US. No abnormality in surrounding parenchyma.
Report Sentence
A _ mm hyperechoic focus with posterior acoustic shadowing is seen in the liver parenchyma; consistent with calcified granuloma.
On T1-weighted imaging, calcified granuloma typically appears as a signal void or markedly hypointense focus. Calcification gives low signal on all MR sequences — hypointense on T1, T2, and gradient echo sequences. No enhancement on gadolinium-enhanced sequences.
Report Sentence
On MR, a signal void hypointense in all sequences is seen in the liver parenchyma without enhancement; consistent with calcified granuloma.
On FDG PET-CT, calcified granuloma shows no metabolic activity — no FDG uptake. This finding confirms that the lesion is metabolically inert and differentiates from active granulomatous disease (sarcoidosis, active TB — FDG positive) and malignant calcified lesions (metastasis — usually FDG positive).
Report Sentence
No increased metabolic activity is seen at the liver calcification on FDG PET-CT; consistent with healed granuloma.
Criteria
TB history or endemic region, coexistence of liver + spleen calcifications, mediastinal/mesenteric calcified lymph nodes, pulmonary apical scar/calcification.
Distinct Features
Usually multiple, small (<5 mm), punctate calcifications. Splenic involvement common. Tuberculin skin test or quantiferon positivity supports but no active disease.
Criteria
Histoplasma endemic region (Ohio/Mississippi valley, Central America), diffuse liver + spleen calcifications, mediastinal/hilar calcified lymph nodes.
Distinct Features
Calcifications may be smaller and more numerous than TB. Bilateral adrenal calcification may coexist. Histoplasma antigen/antibody test supports.
Criteria
Known sarcoidosis history, bilateral hilar lymphadenopathy (may be calcified), liver + spleen involvement, elevated ACE level.
Distinct Features
Sarcoidosis calcifications generally develop later than infectious granulomas. Hepatic involvement detected in <10% on imaging. Eggshell lymph node calcification is specific to sarcoidosis.
Distinguishing Feature
Calcification may be seen in mucinous colorectal metastases but non-calcified soft tissue component and enhancement accompany. In calcified granuloma there is pure calcification, soft tissue component and enhancement are completely absent. Known primary tumor and multiple lesions expected in metastasis.
Distinguishing Feature
In FL-HCC, calcification is located in the central scar of a large mass and surrounding solid tumor tissue shows enhancement. In calcified granuloma there is isolated calcification, no surrounding mass or enhancement. FL-HCC is usually a large (>10 cm) mass in young adults.
Distinguishing Feature
Calcification is rarely seen in hemangioma and usually represents phleboliths of large hemangiomas; the surrounding lesion shows typical hemangioma enhancement pattern (peripheral nodular enhancement + progressive fill-in). No enhancement pattern in calcified granuloma.
Distinguishing Feature
In hydatid cyst, calcification is wall (pericyst) calcification in arc or eggshell pattern; cyst fluid is central. In calcified granuloma there is homogeneous, solid calcification focus — no cystic component. Size difference: hydatid cyst usually >2 cm; granuloma usually <10 mm.
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
no-follow-upCalcified granuloma is a completely benign, healed lesion and requires no treatment or follow-up. When incidentally detected, it should be clearly identified in the radiology report with emphasis on its benign nature — to prevent unnecessary further workup and anxiety. A note of prior granulomatous infection should be made in the presence of multiple calcifications and endemic history. If active disease is suspected (fever, weight loss, lymphadenopathy), clinical evaluation and serological tests should be performed — but isolated calcified granuloma does not indicate active disease.
Completely benign finding requiring no treatment or follow-up. Represents healed remnant of prior tuberculosis or histoplasmosis infection. Classified as LR-1 (definitely benign) in LI-RADS v2018. Noted as incidental finding in reports.